Article
The germline p53 activation syndrome: A new patient further refines the clinical phenotype.
American journal of medical genetics. Part A - 1 Jul 2022
Kumar Runjun D, Tosur Mustafa, Lalani Seema R, Mahoney Donald H, Bertuch Alison A
Abstract excerpt
The tumor suppressor p53 has well known roles in cancer development and germline cancer predisposition disorders, but increasing evidence supports the role of activation of this transcription factor in the pathogenesis of inherited bone marrow failure and chromosomal instability disorders. Here we report a patient with red cell aplasia, which was steroid responsive, as well as intellectual disability, seizures,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
